Pasteur

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:1000 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $4,900,000
  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)
  • Principal Investigator

    N/A

  • Research Location

    India
  • Lead Research Institution

    Institute Pasteur
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Measles Vectored-construct expressing the full length S-protein Phase I safety and immunogenicity Institut Pasteur, Themis Bioscience, University of Pittsburgh

Publicationslinked via Europe PMC

Matrix degradation enhances stress relaxation, regulating cell adhesion and spreading.

Alcohol industry involvement in the delayed South Africa Draft Liquor Amendment Bill 2016: a case study based on freedom of information requests.

Pupil Wizard: an app to enhance knowledge of pupillary abnormalities.

Streptococcus pneumoniae serotype 33H: a novel serotype with frameshift mutations in the acetyltransferase gene wciG.

An enhanced national-scale urban tree canopy cover dataset for the United States.

Impact of postpartum physical activity on maternal anthropometrics: a systematic review and meta-analysis.

Redox dye-mediated fluorescence energy transfer of carbon nanotube-based nanosensors.

Disease burden by <i>ALPL</i> variant number in patients with non-life-threatening hypophosphatasia in the Global HPP Registry.